Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Glycorex Transplantation is an innovative medical technology company based in Sweden, specializing in the development and production of immunoadsorption products. This technology enables the removal of specific antibodies for use in organ transplantation and the treatment of autoimmune diseases.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Glycorex Transplantation is scheduled to report its next quarterly earnings on 08/28/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.